Table 2.
Clinical and radiographical outcomes of the included studies
| Authors | MBML control | MBML test | FSTT control | FSTT test | MBL control | MBL test |
|---|---|---|---|---|---|---|
| Runcharraseng | / | / | 0.32 ± 0.36 | 1.43 ± 0.59 | ||
| Yoshino | 0.70 ± 0.48 | 0.25 ± 0.35 | / | / | − 0.14 ± 0.53 | − 0.01 ± 0.27 |
| Migliorati | 0.37 ± 0.68 | 0.05 ± 0.46 | − 0.10 ± 0.71 | 0.70 ± 1.0 | − 0.136 ± 0.107 | 0.001 ± 0.092 |
| Noelken | 1.00 ± 0.92 | 2.00 ± 0.72 | / | / | / | / |
| Zuiderveld | 0.50 ± 1.10 | 0.10 ± 0.80 | / | / | / | / |
| Frizzera | 0.72 ± 0.57 | 0.04 ± 0.30 | 1.11 ± 0.63 | 2.06 ± 0.68 | − 0.35 ± 3.69 | − 0.55 ± 3.51 |
| De Angelis | / | / | 0.21 ± 0.30 | 0.58 ± 0.45 | / | / |